NCT00324077View on ClinicalTrials.gov

Phase I Study of Dasatinib (BMS-354825) and Imatinib in Subjects With Chronic Myeloid Leukemia in Chronic Phase

PHASE1WithdrawnINTERVENTIONAL
0
Timeline

Start Date

August 31, 2006

Primary Completion Date

February 28, 2007

Conditions
Myeloid Leukemia, Chronic, Chronic-Phase
Interventions
DRUG

Dasatinib in combination with imatinib

Trial Locations (3)

Unknown

Local Institution, Los Angeles

Local Institution, San Francisco

Local Institution, New York

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY

NCT00324077 - Phase I Study of Dasatinib (BMS-354825) and Imatinib in Subjects With Chronic Myeloid Leukemia in Chronic Phase | Biotech Hunter | Biotech Hunter